Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10066
Title: Failure of immune homeostasis -- the consequences of under and over reactivity.
Authors: Crimeen-Irwin, B;Scalzo, K;Gloster, S;Mottram, P L;Plebanski, M
Affiliation: Vaccine and Infectious Disease Laboratory, Austin Research Institute, Austin Hospital, Studley Rd, Heidelberg, Victoria 3084, Australia.
Issue Date: 1-Dec-2005
Citation: Current Drug Targets. Immune, Endocrine and Metabolic Disorders; 5(4): 413-22
Abstract: The immune system is a tightly regulated network that is able to maintain a balance of immune homeostasis under normal physiological conditions. Normally, when challenged with foreign antigen, specific appropriate responses are initiated that are aimed at restoring homeostasis. However under particular circumstances, this balance is not maintained and immune responses either under or over react. Cancer is an example of a situation where the immune response can be inefficient or unresponsive, resulting in uncontrolled growth of the cancer cells. Conversely, when the immune response over-reacts, this can result in conditions such as autoimmunity or pathology following infection. Many drug therapies have been developed that aim to alleviate or prevent such immune disorders and restore immune homeostasis. This review highlights recent advances in immunotherapies, with an emphasis on specific examples in the treatment of cancer, autoimmune disease (multiple sclerosis) and viral infection (respiratory syncytial virus).
Internal ID Number: 16375694
URI: http://ahro.austin.org.au/austinjspui/handle/1/10066
URL: http://www.ncbi.nlm.nih.gov/pubmed/16375694
Type: Journal Article
Subjects: Animals
Autoimmune Diseases.immunology.therapy
Homeostasis.immunology
Humans
Immunotherapy.methods
Neoplasms.immunology.therapy
Virus Diseases.immunology.therapy
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.